Rudi Kundini, Pamoja Kundini
RKPK: Phase II
Strengthening the Continuity of HIV Care in Tanzania With Economic Support: Phase II
2 other identifiers
interventional
692
1 country
4
Brief Summary
This protocol describes an individually randomized trial that will include adult people living with HIV (PLHIV) currently receiving HIV care at one of two participating health facilities and identified as high risk for disengagement from care by a machine learning algorithm. Participants randomized to the control arm will receive standard of care HIV clinical services according to Tanzania's National Guidelines for the management of HIV. For those who meet clinic eligibility criteria for enhanced adherence counseling, which at the included study sites is when client's viral load reaches a detectable level (\>1000 copies/ml), this includes the standard provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions, starting on the day of the result and for two months after. Intervention arm participants will receive the same standard HIV care services plus the offer of a cash transfer paired with visit attendance and attendance at each of the three adapted enhanced adherence counseling sessions (referred to as PKC sessions).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2022
CompletedFirst Posted
Study publicly available on registry
May 13, 2022
CompletedStudy Start
First participant enrolled
October 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2026
CompletedJuly 30, 2025
July 1, 2025
2.2 years
May 9, 2022
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
12-Month Viral Suppression
The proportion of people living with HIV (PLHIV) and on ART with suppressed HIV viral load ( \<1000 copies/ml) at 12 months after study enrollment.
12 months
Secondary Outcomes (19)
6-month retention in care
6 months
12-month retention in care
12 months
12-month durable viral load
12 months
12-month Appointment Attendance
12 months
6-month Appointment Attendance
6 months
- +14 more secondary outcomes
Study Arms (2)
Adapted Adherence Counseling (PKC) and Conditional Cash Transfers
EXPERIMENTALEligible and consenting participants randomized to the intervention arm will receive the same standard HIV clinical services according Tanzania's National Guidelines for the Management of HIV as the comparison arm, which includes provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions adapted for study purposes (PKC sessions). Counseling focuses on the meaning of viral loads and supportive, non-judgmental strategies for adherence and visit attendance. A minimum of three sessions are required. In addition to enhanced adherence counseling, intervention participants will receive the offer of a cash transfer paired with attendance at each of the three enhanced adherence counseling sessions. The first payment will occur at enrollment; the next two cash transfers are payable upon visit attendance and attendance of the two remaining enhanced adherence counseling sessions.
Enhanced Adherence Counseling only for those who qualify
NO INTERVENTIONEligible and consenting participants randomized to the control arm will receive standard of care HIV clinical services according to Tanzania's National Guidelines for the Management of HIV. For those who meet clinic eligibility criteria for enhanced adherence counseling, this includes the standard provision of three, once-monthly, 60-minute nurse-led individual, enhanced adherence counseling sessions, starting on the day of a detectable viral load result and for two months after. Counseling focuses on the meaning of viral loads and supportive, non-judgmental strategies for adherence and visit attendance. A minimum of three sessions are required.
Interventions
The intervention includes up to 3 cash transfers of 22,500 Tanzanian Shillings (\~$10) paired with attendance at each of the three adapted enhanced adherence counseling sessions (PKC sessions). The first cash transfer will occur at enrollment; the next two cash transfers are payable upon visit attendance and attendance of the two remaining PKC sessions. The cash transfers will include extra funds for transaction fees, typically \<$1.
Eligibility Criteria
You may qualify if:
- PLHIV on ART;
- Age 18 years or older;
- Phone ownership OR consistent phone access;
- Not already enrolled in/currently attending enhanced adherence counseling sessions at the facility
- Living in Geita Region and intends to receive care at a study facility for the next 12 months;
- Classified as "high-risk" for loss to follow-up (LTFU) from HIV care, and
- Provides written informed consent for participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Berkeleylead
- Health for a Prosperous Nationcollaborator
- Rasellocollaborator
- Management and Development for Healthcollaborator
- Ministry of Health, Tanzaniacollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (4)
Geita Regional Referral Hospital
Geita, Tanzania
Geita Town Council Hospital
Geita, Tanzania
Nyankumbu Health Center
Geita, Tanzania
Katoro Health Center
Katoro, Tanzania
Related Publications (2)
Kadota JL, Packel LJ, Mlowe M, Ulenga N, Mwenda N, Njau PF, Dow WH, Wang J, Sabasaba A, McCoy SI. Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania. Trials. 2024 Feb 10;25(1):114. doi: 10.1186/s13063-024-07960-x.
PMID: 38336793DERIVEDKadota JL, Packel LJ, Mlowe M, Ulenga N, Mwenda N, Njau PF, Dow WH, Wang J, Sabasaba A, McCoy SI. Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania. Res Sq [Preprint]. 2023 Dec 20:rs.3.rs-3315136. doi: 10.21203/rs.3.rs-3315136/v1.
PMID: 38196655DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jingshen Wang, PhD
University of California, Berkeley
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Laboratory staff analyzing viral load samples will be blind to intervention/control attribution.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2022
First Posted
May 13, 2022
Study Start
October 23, 2023
Primary Completion
January 20, 2026
Study Completion
January 20, 2026
Last Updated
July 30, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Access Criteria
- Provided upon request